Advanced Cell Technology, Inc. is a biotechnology company that develops human embryonic and adult stem cell technology. The company has ownership/licensing of approximately 37 patents and approximately 190 patent applications pending in the regenerative medicine and stem cell therapy fields. It is also running clinical trials for treating macular degeneration and has a pre-clinical development pipeline focused on products for eye diseases, autoimmune and inflammatory diseases, and wound healing. For more information, visit the company’s website at www.advancedcell.com.